- Home
- PGEN vs REAL Comparison
PGEN vs REAL Comparison
Compare PGEN & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- REAL
- Stock Information
- Founded
- PGEN 1998
- REAL 2011
- Country
- PGEN United States
- REAL United States
- Employees
- PGEN N/A
- REAL N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- REAL Other Specialty Stores
- Sector
- PGEN Health Care
- REAL Consumer Discretionary
- Exchange
- PGEN Nasdaq
- REAL Nasdaq
- Market Cap
- PGEN 292.6M
- REAL 982.8M
- IPO Year
- PGEN N/A
- REAL 2019
- Fundamental
- Price
- PGEN $0.79
- REAL $9.33
- Analyst Decision
- PGEN Buy
- REAL Buy
- Analyst Count
- PGEN 5
- REAL 6
- Target Price
- PGEN $7.00
- REAL $7.04
- AVG Volume (30 Days)
- PGEN 1.1M
- REAL 3.8M
- Earning Date
- PGEN 11-14-2024
- REAL 11-04-2024
- Dividend Yield
- PGEN N/A
- REAL N/A
- EPS Growth
- PGEN N/A
- REAL N/A
- EPS
- PGEN N/A
- REAL N/A
- Revenue
- PGEN $3,963,000.00
- REAL $579,862,000.00
- Revenue This Year
- PGEN N/A
- REAL $11.26
- Revenue Next Year
- PGEN $402.12
- REAL $8.81
- P/E Ratio
- PGEN N/A
- REAL N/A
- Revenue Growth
- PGEN N/A
- REAL 2.52
- 52 Week Low
- PGEN $0.65
- REAL $1.52
- 52 Week High
- PGEN $1.93
- REAL $9.78
- Technical
- Relative Strength Index (RSI)
- PGEN 49.30
- REAL 73.17
- Support Level
- PGEN $0.71
- REAL $8.54
- Resistance Level
- PGEN $0.79
- REAL $9.73
- Average True Range (ATR)
- PGEN 0.05
- REAL 0.73
- MACD
- PGEN 0.01
- REAL -0.00
- Stochastic Oscillator
- PGEN 75.11
- REAL 88.10
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.